Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoke Chuanling Oral Liquid is a designation that appears to combine two distinct Traditional Chinese Medicine (TCM) products manufactured by Juneng Golden Key Pharmaceutical (Wuhan Juneng Jinshi Pharmaceutical): **Xiaoke Oral Liquid** (消渴口服液) and **Chuanling Oral Liquid** (喘灵口服液). Xiaoke Oral Liquid is an approved TCM formulation (NMPA registration Z20025051) indicated for nourishing Yin, tonifying the kidney, and promoting body fluids to treat symptoms associated with Type 2 diabetes (Xiaoke). Chuanling Oral Liquid (NMPA registration Z20025052) is indicated for ventilating the lungs, resolving phlegm, and relieving cough and asthma (Chuan) associated with respiratory conditions such as chronic bronchitis. Both products are approved by the National Medical Products Administration (NMPA) in China and are administered orally as liquid solutions. The name 'Xiaoke Chuanling' likely stems from a concatenation of these two separate but consecutively registered products in manufacturer listings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoke Chuanling Oral Liquid.